nodes	percent_of_prediction	percent_of_DWPC	metapath
Benzylpenicilloyl Polylysine—FCER1A—IL1 and megakaryotyces in obesity—MMP9—bile duct cancer	0.161	0.161	CbGpPWpGaD
Benzylpenicilloyl Polylysine—FCER1A—Fc-epsilon receptor I signaling in mast cells—HRAS—bile duct cancer	0.0496	0.0496	CbGpPWpGaD
Benzylpenicilloyl Polylysine—FCER1G—Platelet activation, signaling and aggregation—HGF—bile duct cancer	0.0437	0.0437	CbGpPWpGaD
Benzylpenicilloyl Polylysine—FCER1G—Fc-epsilon receptor I signaling in mast cells—HRAS—bile duct cancer	0.0392	0.0392	CbGpPWpGaD
Benzylpenicilloyl Polylysine—FCER1A—Fc epsilon receptor (FCERI) signaling—ERBB2—bile duct cancer	0.038	0.038	CbGpPWpGaD
Benzylpenicilloyl Polylysine—FCER1G—Cell surface interactions at the vascular wall—NRAS—bile duct cancer	0.0364	0.0364	CbGpPWpGaD
Benzylpenicilloyl Polylysine—FCER1G—Cell surface interactions at the vascular wall—KRAS—bile duct cancer	0.0313	0.0313	CbGpPWpGaD
Benzylpenicilloyl Polylysine—FCER1G—Fc epsilon receptor (FCERI) signaling—ERBB2—bile duct cancer	0.0301	0.0301	CbGpPWpGaD
Benzylpenicilloyl Polylysine—FCER1A—Fc epsilon receptor (FCERI) signaling—NRAS—bile duct cancer	0.0289	0.0289	CbGpPWpGaD
Benzylpenicilloyl Polylysine—FCER1G—Cell surface interactions at the vascular wall—HRAS—bile duct cancer	0.0266	0.0266	CbGpPWpGaD
Benzylpenicilloyl Polylysine—FCER1A—Fc epsilon receptor (FCERI) signaling—EGFR—bile duct cancer	0.0264	0.0264	CbGpPWpGaD
Benzylpenicilloyl Polylysine—FCER1A—Fc epsilon receptor (FCERI) signaling—KRAS—bile duct cancer	0.0249	0.0249	CbGpPWpGaD
Benzylpenicilloyl Polylysine—FCER1G—Hemostasis—GNAS—bile duct cancer	0.0236	0.0236	CbGpPWpGaD
Benzylpenicilloyl Polylysine—FCER1G—Fc epsilon receptor (FCERI) signaling—NRAS—bile duct cancer	0.0229	0.0229	CbGpPWpGaD
Benzylpenicilloyl Polylysine—FCER1G—Hemostasis—HGF—bile duct cancer	0.0225	0.0225	CbGpPWpGaD
Benzylpenicilloyl Polylysine—FCER1A—Fc epsilon receptor (FCERI) signaling—HRAS—bile duct cancer	0.0212	0.0212	CbGpPWpGaD
Benzylpenicilloyl Polylysine—FCER1G—Fc epsilon receptor (FCERI) signaling—EGFR—bile duct cancer	0.0208	0.0208	CbGpPWpGaD
Benzylpenicilloyl Polylysine—FCER1A—Fc epsilon receptor (FCERI) signaling—IL6—bile duct cancer	0.0203	0.0203	CbGpPWpGaD
Benzylpenicilloyl Polylysine—FCER1G—Fc epsilon receptor (FCERI) signaling—KRAS—bile duct cancer	0.0197	0.0197	CbGpPWpGaD
Benzylpenicilloyl Polylysine—FCER1G—Platelet activation, signaling and aggregation—TGFB1—bile duct cancer	0.0178	0.0178	CbGpPWpGaD
Benzylpenicilloyl Polylysine—FCER1G—Hemostasis—NOS2—bile duct cancer	0.0173	0.0173	CbGpPWpGaD
Benzylpenicilloyl Polylysine—FCER1G—Fc epsilon receptor (FCERI) signaling—HRAS—bile duct cancer	0.0167	0.0167	CbGpPWpGaD
Benzylpenicilloyl Polylysine—FCER1G—Fc epsilon receptor (FCERI) signaling—IL6—bile duct cancer	0.016	0.016	CbGpPWpGaD
Benzylpenicilloyl Polylysine—FCER1A—Immune System—HGF—bile duct cancer	0.0149	0.0149	CbGpPWpGaD
Benzylpenicilloyl Polylysine—FCER1A—Innate Immune System—ERBB2—bile duct cancer	0.0148	0.0148	CbGpPWpGaD
Benzylpenicilloyl Polylysine—FCER1G—Immune System—HGF—bile duct cancer	0.0118	0.0118	CbGpPWpGaD
Benzylpenicilloyl Polylysine—FCER1G—Innate Immune System—ERBB2—bile duct cancer	0.0117	0.0117	CbGpPWpGaD
Benzylpenicilloyl Polylysine—FCER1A—Innate Immune System—NRAS—bile duct cancer	0.0112	0.0112	CbGpPWpGaD
Benzylpenicilloyl Polylysine—FCER1A—Innate Immune System—EGFR—bile duct cancer	0.0102	0.0102	CbGpPWpGaD
Benzylpenicilloyl Polylysine—FCER1G—Hemostasis—NRAS—bile duct cancer	0.00987	0.00987	CbGpPWpGaD
Benzylpenicilloyl Polylysine—FCER1A—Innate Immune System—KRAS—bile duct cancer	0.00968	0.00968	CbGpPWpGaD
Benzylpenicilloyl Polylysine—FCER1G—Hemostasis—TGFB1—bile duct cancer	0.00917	0.00917	CbGpPWpGaD
Benzylpenicilloyl Polylysine—FCER1G—Innate Immune System—NRAS—bile duct cancer	0.00889	0.00889	CbGpPWpGaD
Benzylpenicilloyl Polylysine—FCER1A—Immune System—ERBB2—bile duct cancer	0.00861	0.00861	CbGpPWpGaD
Benzylpenicilloyl Polylysine—FCER1G—Hemostasis—KRAS—bile duct cancer	0.0085	0.0085	CbGpPWpGaD
Benzylpenicilloyl Polylysine—FCER1A—Innate Immune System—HRAS—bile duct cancer	0.00822	0.00822	CbGpPWpGaD
Benzylpenicilloyl Polylysine—FCER1G—Innate Immune System—EGFR—bile duct cancer	0.0081	0.0081	CbGpPWpGaD
Benzylpenicilloyl Polylysine—FCER1A—Innate Immune System—IL6—bile duct cancer	0.00787	0.00787	CbGpPWpGaD
Benzylpenicilloyl Polylysine—FCER1G—Innate Immune System—KRAS—bile duct cancer	0.00765	0.00765	CbGpPWpGaD
Benzylpenicilloyl Polylysine—FCER1G—Hemostasis—TP53—bile duct cancer	0.00755	0.00755	CbGpPWpGaD
Benzylpenicilloyl Polylysine—FCER1G—Hemostasis—HRAS—bile duct cancer	0.00722	0.00722	CbGpPWpGaD
Benzylpenicilloyl Polylysine—FCER1G—Immune System—ERBB2—bile duct cancer	0.0068	0.0068	CbGpPWpGaD
Benzylpenicilloyl Polylysine—FCER1A—Immune System—NRAS—bile duct cancer	0.00655	0.00655	CbGpPWpGaD
Benzylpenicilloyl Polylysine—FCER1G—Innate Immune System—HRAS—bile duct cancer	0.0065	0.0065	CbGpPWpGaD
Benzylpenicilloyl Polylysine—FCER1G—Innate Immune System—IL6—bile duct cancer	0.00622	0.00622	CbGpPWpGaD
Benzylpenicilloyl Polylysine—FCER1A—Immune System—EGFR—bile duct cancer	0.00597	0.00597	CbGpPWpGaD
Benzylpenicilloyl Polylysine—FCER1A—Immune System—KRAS—bile duct cancer	0.00564	0.00564	CbGpPWpGaD
Benzylpenicilloyl Polylysine—FCER1G—Immune System—NRAS—bile duct cancer	0.00518	0.00518	CbGpPWpGaD
Benzylpenicilloyl Polylysine—FCER1A—Immune System—HRAS—bile duct cancer	0.00479	0.00479	CbGpPWpGaD
Benzylpenicilloyl Polylysine—FCER1G—Immune System—EGFR—bile duct cancer	0.00472	0.00472	CbGpPWpGaD
Benzylpenicilloyl Polylysine—FCER1A—Immune System—IL6—bile duct cancer	0.00458	0.00458	CbGpPWpGaD
Benzylpenicilloyl Polylysine—FCER1G—Immune System—KRAS—bile duct cancer	0.00445	0.00445	CbGpPWpGaD
Benzylpenicilloyl Polylysine—FCER1G—Immune System—HRAS—bile duct cancer	0.00379	0.00379	CbGpPWpGaD
Benzylpenicilloyl Polylysine—FCER1G—Immune System—IL6—bile duct cancer	0.00362	0.00362	CbGpPWpGaD
